Search

LONDON & NEW DELHI—India can achieve universal healthcare for all its citizens by the year 2020 according to Dr A. K. Shiva Kumar, economist and advisor to UNICEF India in New Delhi, who is one o

NEW DELHI—Although clinical studies have suggested that the cholesterol lowering drugs known as statins could benefit people who are not already ill with cardiovascular disease, this assumption may ha

To prevent AIDS it is essential to identify the factors driving the risk of infection in a particular community, rather than just applying a good — but un-researched — idea or a “one size fits a

The global battle against AIDS needs a ‘Robin Hood Tax’ to raise finance: rich countries need to shoulder the cost of fighting the pandemic in poor countries — as well as at home — in the

LONDON—Fighting AIDS in the future will need strong action and continued high levels of funding according to experts meeting at the London School of Hygiene and Tropical Medicine. At a symposium held

LONDON—Despite the need for cost savings in the UK economy, the British government is committed to prioritising key strategies for fighting HIV/AIDS both at home and globally, according to Peter Colen

ORLANDO—The immunotoxin brentuximab vedotin (SGN 35) has shown efficacy in relapsed and refractory Hodgkin’s Disease in a study from California reported at the American Society of Hematology ann

London School of Hygiene and Tropical Medicine World AIDS Day Symposium report: Derek Thorne and Sarah Maxwell interview researchers about the prospects for controlling HIV/AIDS

ORLANDO—In new research the Stanford V chemotherapy regimen for Hodgkin’s Disease was inferior to ABVD because it required “obligate radiotherapy” — according to George Canellos of t

ORLANDO—The immunotoxin brentuximab vedotin (SGN 35) has shown efficacy in relapsed and refractory Hodgkin’s Disease in a study from California reported at the American Society of Hematology ann

ORLANDO—Lenalidomide maintenance therapy extended times to disease progression among patients whose multiple myeloma had been treated with autologous stem cell transplantation in a phase III study rep

ORLANDO—Primary mediastinal large B cell lymphoma responded excellently to a dose-dense schedule of R-CHOP immuno-chemotherapy followed by ICE chemotherapy — without the need for radiotherapy — in a s